|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1420 NEW YORK AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | MINNEAPOLIS |
State | MN |
Zip Code | 55432 |
Country | USA |
|
5. Senate ID# 24817-12
|
||||||||
|
6. House ID# 310490000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Peter Slone, Vice President of Government Affairs |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 1908-Patent Reform, provisions relating to the treatment of innovative technologies; S. 1145-Patent Reform, provisions relating to the treatment of innovative technologies
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3014-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; S 1576-Health Disparities, provisions relating to the treatment of heart disease patients in minority populations with a focus on SCA; H.R. 2994-National Pain Care Policy Act of 2008, provisions related to pain care management and treatment;H.R. 6381- Medical Device Safety Act - provision related to preserving statutory federal preemption;
S. 3398 - Medical Device Safety Act - provision related to preserving statutory federal preemption;
S. 3387 - National Pain Care Policy Act of 2008 - provisions related to pain care management and treatment
S. 3408 - Comparative Effectiveness Research Act of 2008 - provisions related to the establishment of a new entity to conduct comparative effectiveness research.
S. 3409 - Drug and Device Accountability Act of 2008 - provisions related to device and drug import safety
H.R. 4926 - Josh Miller Hearts Act - provisions related to establishing a grant program to ensure every elementary and secondary school in the country can obtain AEDs.
H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 - provisions that might affect combination products
H.R. 1028 - To create a Rural Policing Institute as part of the Federal Law Enforcement Training Center- provisions that might affect combination products
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 - provisions that might affect combination products
S. 1695 - Follow-on Biologics - provisions that might affect combination products
S. 1693 - Health Information Technology - provisions related to enhancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States.
H.R. 3800 - Promoting Health Information Technology Act - provisions related to advancing the adoption of nationwide interoperable health information technology system, improving health care quality and reducing health care costs in the United States.
H.R. 2184 - Enhanced Healthcare Value for All Act of 2007- provisions to expand comparative effectiveness research
S.2221 - Transparency in Medical Device Pricing Act - provisions related to pricing for medical devices
S.2029 - Physician Payments Sunshine Act of 2007- provisions related to providing transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies
H.R. 3023 - Drug and Medical Device Company Gift Disclosure Act - provisions requiring manufacturers, packers and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes
H.R. 5839 - Safeguarding America's Pharmaceuticals Act. Provisions that require tagging of pharmaceuticals with standardized numerical identifiers to track drug in all parts of supply chain.
S. 3568 - To amend the Controlled Substances Act relative to the use of intrathecal pumps.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Theresa |
Doyle |
|
|
|
Peter |
Slone |
|
|
|
Jessica |
Battaglia |
|
|
|
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4105 - Medicare Recovery Audit Contractor Moratorium Act of 2007 - provisions related to impact on medical technology
H.R. 6331 - Medicare Improvements for Patients and Providers Act of 2008 - provisions relationed to healthcare disparaties, preventive health care, access to care in rural areas, physician fee schedule and medical technology
H.R.6163 - To improve the provision of telehealth services under the Medicare Program - to provide grants for the development of telehealth networks, and for other purposes - provisions related to remote monitoring
S 631- Remote Monitoring Access Act of 2007 - provisions related to coverage of remote patient management services for chronic health care conditions under the Medicare Program.
HR 5765 - Medicare Remote Monitoring Access Act of 2008 - provisions related to coverage of remote patient management services for certain chronic health conditions under the Medicare Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Theresa |
Doyle |
|
|
|
Peter |
Slone |
|
|
|
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
S. 3001 - National Defense Authorization Act for Fiscal Year 2009 - provisions related to pain care management and treatment
HR 5465 - Military Pain Care Act of 2008 - provisions related to pain care initiative in Department of Defense health care program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Theresa |
Doyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 2162 - Veterans' Mental Health and Other Care Improvements Act of 2008 - provisions related to the pain care policy for veterans
HR 6122 -Veterans Pain Care Act of 2008 - provisions related to the pain care policy for veterans
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Theresa |
Doyle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |